Molecular Mimics of the Tumour Antigen MUC1
Citation:James, T.C. and U, Bond, Molecular Mimics of the Tumour Antigen MUC1, PLOS One, 7, 11, 2012, 1-10
journal.pone.0049728.pdf (Published (publisher's copy) - Peer Reviewed) 642.1Kb
A key requirement for the development of cancer immunotherapy is the identification of tumour-associated antigens that are differentially or exclusively expressed on the tumour and recognized by the host immune system. However, immune responses to such antigens are often muted or lacking due to the antigens being recognized as "self", and further complicated by the tumour environment and regulation of immune cells within. In an effort to circumvent the lack of immune responses to tumour antigens, we have devised a strategy to develop potential synthetic immunogens. The strategy, termed mirror image phage display, is based on the concept of molecular mimicry as demonstrated by the idiotype/anti-idiotype paradigm in the immune system. Here as 'proof of principle' we have selected molecular mimics of the well-characterised tumour associated antigen, the human mucin1 protein (MUC1) from two different peptide phage display libraries. The putative mimics were compared in structure and function to that of the native antigen. Our results demonstrate that several of the mimic peptides display T-cell stimulation activity in vitro when presented by matured dendritic cells. The mimic peptides and the native MUC1 antigenic epitopes can cross-stimulate T-cells. The data also indicate that sequence homology and/or chemical properties to the original epitope are not the sole determining factors for the observed immunostimulatory activity of the mimic peptides.
Type of material:Journal Article
Series/Report no:PLOS One
Availability:Full text available
Keywords:gamma interferon; interleukin 12; lipopolysaccharide; mucin 1; tumor antigen; tumor necrosis factor alpha